APOA1 rs670: Understanding This Genetic Variant and Lipid Metabolism
The rs670 variant is a common single-nucleotide polymorphism located in the promoter region of the APOA1 gene. It is frequently studied for its potential influence on high-density lipoprotein (HDL) cholesterol concentrations and various markers of metabolic health.
What each genotype means
A-allele carrier profile
This genotype is sometimes referred to as the -75A variant in scientific literature. Research suggests that individuals with this genotype may show different responses to dietary interventions regarding insulin resistance and lipid levels compared to those with the G allele, though these associations are context-dependent and vary across populations.
This genotype is less common than the G/G genotype in many global populations.
Heterozygous variant profile
Carrying one copy of each allele means you possess both the A and G versions of this site. Studies indicate that the APOA1 gene is highly polymorphic and this specific variant may influence how your body processes lipids, particularly in response to specific dietary patterns or metabolic stressors.
This is a common genotype found in many populations, often appearing in a significant portion of European and East Asian cohorts.
Common homozygous profile
This is often considered the major or reference allele at this position in many populations. While this genotype is associated with baseline lipid metabolism, individual lipid levels are influenced by a complex interplay of many genetic and environmental factors.
This is the most frequently observed genotype across most studied European and East Asian populations.
What is the rs670 Variant?
The rs670 variant is a specific genetic change, technically described as a cytosine-to-thymine (C>T) transition, located in the promoter region of the APOA1 gene. The promoter region acts as a control switch for a gene, determining how much of a protein is produced. Because rs670 sits in this regulatory area, researchers have long hypothesized that it may influence the expression levels of the APOA1 gene. This variant is found on chromosome 11 and is considered a common polymorphism, meaning it appears frequently across diverse human populations. By studying this site, scientists aim to understand how subtle variations in our DNA sequence can lead to differences in how our bodies process fats and cholesterol, which are essential components of cardiovascular and metabolic health.
The Role of the APOA1 Gene
The APOA1 gene provides the instructions for creating apolipoprotein A-I (apoA-I), a protein that serves as the primary structural component of high-density lipoprotein (HDL). Often referred to as 'good' cholesterol, HDL plays a critical role in reverse cholesterol transport, a process where cholesterol is moved from body tissues back to the liver for excretion or recycling. Beyond its role in lipid transport, apoA-I acts as a necessary cofactor for enzymes that help maintain healthy cholesterol levels. When the APOA1 gene functions normally, it supports efficient lipid metabolism. However, significant mutations in this gene can lead to rare conditions like familial HDL deficiency. While rs670 is a common variant rather than a rare disease-causing mutation, its location in the promoter region makes it a subject of interest for those studying how gene regulation impacts overall lipid profiles.
Research Associations and Evidence Strength
Research into rs670 has produced mixed and sometimes conflicting results regarding its clinical impact. Many observational studies have linked the variant to variations in HDL cholesterol levels, insulin resistance, and metabolic syndrome. Some meta-analyses suggest that the presence of the polymorphic allele may be associated with an increased risk of metabolic disorders, while other studies have explored its role in how individuals respond to different dietary interventions or pharmacological treatments. It is important to note that the evidence strength for rs670 as a direct, standalone predictor of cardiovascular disease is limited. Recent Mendelian randomization studies, which use genetic variants to mimic the effects of lifelong exposure, have often failed to find a clear causal link between specific APOA1 variants and cardiovascular outcomes. Consequently, while rs670 is a useful marker in genetic research, it should not be viewed as a definitive diagnostic tool for heart health.
Population Frequency
The rs670 variant is widely distributed across the globe. Data from various genomic projects indicate that the minor allele frequency typically ranges between 0.10 and 0.20 in European and East Asian cohorts. Some studies suggest that the variant occurs in more than 20% of the global population, making it a very common feature of human genetic diversity. Because it is so prevalent, it is considered a normal part of the genetic landscape rather than a rare or pathogenic mutation. Frequency can vary significantly depending on ancestral background, which is a common theme in population genetics. Researchers continue to monitor these frequencies to better understand how the variant interacts with different environmental and lifestyle factors across diverse groups.
What This Information Means for You
Understanding your genotype for rs670 provides a glimpse into the complex interplay between your DNA and your metabolism, but it does not provide a medical diagnosis. Genetic associations are statistical observations made across large groups of people and do not necessarily predict individual health outcomes. Many factors, including diet, physical activity, age, and other genetic markers, contribute to your lipid profile and metabolic health. If you have concerns about your cholesterol levels or metabolic markers, the most effective approach is to consult with a healthcare professional. They can interpret your clinical blood work and provide personalized guidance. Never use genetic information to make decisions about medication or lifestyle changes without first discussing them with your doctor or a qualified pharmacist, as they can help you weigh the evidence in the context of your overall health history.
How common is this variant?
The rs670 variant is common, with a minor allele frequency typically ranging from 0.10 to 0.20 across European and East Asian populations.
Frequently asked questions
Is rs670 a cause of heart disease?
No, rs670 is not considered a direct cause of heart disease. While it is associated with variations in HDL cholesterol levels, current research does not support it as a standalone causal factor for cardiovascular events.
Should I change my diet based on my rs670 genotype?
You should not make dietary changes based solely on this genetic variant. Always consult with a registered dietitian or your physician to create a nutrition plan tailored to your specific health needs and clinical blood markers.
Does rs670 affect how I respond to cholesterol medication?
Some studies explore how genetic variants influence drug response, but there is no standard clinical recommendation for using rs670 to guide cholesterol medication. Discuss any concerns about your medication with your doctor or pharmacist.
Where can I find more information about the APOA1 gene?
MedlinePlus Genetics is an excellent, reliable resource for learning about the function of the APOA1 gene and its role in human health. You can also search the NCBI Gene database for technical details.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs670?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29